Poland· PL-100422070

Cetraxal Plus

A fluocinolon acetonid und antiinfektiva product containing ciprofloxacinum + fluocinoloni acetonidum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.

ATC S02CA05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCetraxal PlusATCS02CA05REGISTER NO.PL-100422070PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Fluocinolon acetonid und antiinfektiva is registered in 7 of 19 countries.

Countries holding a registration under ATC S02CA05 (fluocinolon acetonid und antiinfektiva), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Fluocinolon acetonid und antiinfektiva · ATC S02CA05

7 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ciprofloxacinum + Fluocinoloni acetonidum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
S02CA05
ATC class
Fluocinolon acetonid und Antiinfektiva
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991406271

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluocinolon acetonid und antiinfektiva in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluocinolon acetonid und antiinfektiva products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Infectociprocort
  • Czechia · Infalin Duo
  • Germany · Infectociprocort
  • Denmark · Cetraxal Comp, Cetraxal Comp Ukonserveret
  • Estonia · Bonadix
  • Spain · Aceoto Plus, Cetraxal Plus
  • Finland · Cetraxal Comp
  • France · Cetraxal
  • United Kingdom (Northern Ireland) · Cetraxal Plus
  • Greece · Otospon
  • Croatia · Ciprofloksacin/Flucinolonacetonid Goodwill
  • Hungary · Duoxal
  • Iceland · Cetraxal Comp
  • Italy · Cexidal
  • Lithuania · Bonadix
  • Latvia · Bonadix
  • Malta · Cetraxal Plus
  • Norway · Cetraxal Comp
  • Portugal · Cetraxal Duo
  • Romania · Cexidal, Ototis
  • Sweden · Cetraxal Comp
  • Slovakia · Infalin Duo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff02cfd5-e2d1-4667-9010-a6eb13f5cccb
GET /v1/drugs/ff02cfd5-e2d1-4667-9010-a6eb13f5cccb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do uszu, roztwór",
  "source": "urpl",
  "strength": "3 mg/ml + 0,25 mg/ml",
  "packaging": "05909991406271 ¦ Rp ¦ 133013\n1 butelka 10 ml",
  "substance": "Ciprofloxacinum 3 mg/ml + Fluocinoloni acetonidum 0.25 mg/ml",
  "common_name": "Ciprofloxacinum + Fluocinoloni acetonidum",
  "pl_product_id": "100422070",
  "pozwolenie_nr": "226/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-06-13"
}

See everything about fluocinolon acetonid und antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.